News and views for the UB community
The Templeton Foundation is funding the innovative project that will show how diversity, disagreement and dynamism are crucial for an open society.
Nine partners — including two in Buffalo — will either start or expand a mobile produce market as part of a UB research project.
UB researchers’ insights into a target that succeeded in animals but failed in humans reveal a new paradigm for screening Alzheimer’s drugs.
The advancement, made possible by tiny photonic implants, could lead to new treatments for cancer and mental disorders like schizophrenia.
The Department of Chemistry’s CHEM 360° initiative offers undergrads a summer of lab work, as well as instruction on ethics and social media.
UB’s physics department is hosting a conference this week for researchers working with the Large Hadron Collider.
The findings suggest that the country may need to re-evaluate its standards for nitrogen dioxide.
A study of survivors’ near-miss experiences on 9/11 contributes to an understanding of what counts as exposure trauma.
UB faculty member Jun-Xu Li has received a $2M NIH grant to look at a receptor that has recently emerged as a novel target for treating drug addiction.
The new guidelines could offer an alternative to opioids to treat oral mucositis, the painful side effect of head and neck cancer treatment.
A study found that while the commonly used imaging linear contrast agent does accumulate in the brain, there is no discernible clinical impact.